Certain medical conditions should also be noted, such as kidney disease, low potassium and other nutritional deficiencies
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was initially approved in 2020 as a treatment method for improving glycemic control in patients with Type 2 diabetes
Propanediol, 1,2-Hexanediol, Glycerin, Hydroxyacetophenone, Betaine, Mineral Salt, Panthenol , Ethylhexylglycerin, Sodium Polyacryloyldimethyl Taurate, Disodium EDTA, Butylene Glycol, Salix Alba (Willow) Bark Extract, Castanea Crenata Shell Extract, Lavandula Angustifolia (Lavender) Flower Extract, Hyaluronic Acid, Hydrolyzed Hyaluronic Acid, Sodium Hyaluronate, Allatoin, Citric Acid, Capryloyl Salicylic Acid, Gluconolactone, Sodium Citrate, Salicylic Acid, Glycolic Acid, etc
J Biol Chem 286(11):91969204 Kiriakov A, Khlebarova M, Staneva-Stoicheva D, Panova I (1973) The effect of prolonged treatment hypertensive rats with antihypertensive agents with different mechanisms of action on blood pressure and noradrenaline concentration in the myocardium, brain and aorta